Massachusetts H1296 protects 340B providers from discriminatory practices by insurers and manufacturers.
The Massachusetts H1296 bill aims to protect 340B providers by prohibiting discriminatory practices by health insurance issuers, pharmacy benefit managers, and manufacturers. It ensures that 340B entities, which participate in the federal 340B drug discount program, are not subjected to lower reimbursement rates, additional fees, or unnecessary administrative burdens compared to non-340B entities. The bill also mandates that manufacturers and distributors cannot interfere with the acquisition or delivery of 340B drugs to pharmacies contracted with 340B entities.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.